Lower vs. standard radiation doses for nasopharyngeal cancer treatment

This trial is testing whether patients with nasopharyngeal cancer can be safely treated with a lower dose of radiation therapy instead of the standard higher dose. Researchers want to know if reducing radiation to certain low-risk areas of the neck and head works just as well at controlling the cancer while potentially reducing long-term side effects and improving quality of life.

Standard radiation therapy for nasopharyngeal cancer can cause lasting problems like difficulty swallowing, dry mouth, and hearing loss. This trial exists to find out whether using a lower radiation dose in certain areas might be effective while sparing patients from some of these difficult side effects.